About us

Primary Immune disorders affect 15,000 new patients every year in Europe.

Genetic tests are usually performed on a single or very limited number of genes leaving the majority of patients without a genetic diagnosis.

The GRID platform is a single and affordable DNA-based test for genes involved in primary immune disorders. As well as simultaneously screening multiple genes, the GRID platform test will scan most of the possible mutations in those regions, from just a single blood sample.